Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve audited financial results of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Parmax Pharma Ltd has notified BSE that its Board of Directors meeting is scheduled for May 30, 2026. The meeting will consider and approve the audited financial results for the quarter and financial year ending March 31, 2026. The company has also confirmed that the trading window for insiders has been closed and will remain shut until 48 hours after the results announcement. This is a standard regulatory compliance filing under SEBI Listing Regulations. No specific financial figures or additional details have been disclosed in this intimation.
This is a routine filing that signals upcoming Q4/FY2026 results announcement. Investors should note the trading window closure period for insider trading compliance. The actual impact on the stock will depend on the financial results to be disclosed on May 30, 2026.